Dissemin is shutting down on January 1st, 2025

Published in

Elsevier Masson, Antiviral Research, 2(99), p. 172-179

DOI: 10.1016/j.antiviral.2013.05.012

Links

Tools

Export citation

Search in Google Scholar

Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid

Journal article published in 2013 by Ángela Vázquez-Calvo, Miguel A. Martín-Acebes, Juan-Carlos Sáiz, Nhi Ngo, Francisco Sobrino ORCID, Juan Carlos de la Torre
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Valproic acid (VPA), a short chain fatty acid commonly used for treatment of neurological disorders, has been shown to inhibit production of infectious progeny of different enveloped viruses including the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). In this study we have investigated the mechanisms by which VPA inhibits LCMV multiplication in cultured cells. VPA reduced production of infectious LCMV progeny and virus propagation without exerting a major blockage on either viral RNA or protein synthesis, but rather affecting the cell release and specific infectivity of LCMV progeny from infected cells. Our results would support the repurposing of VPA as a candidate antiviral drug to combat arenavirus infections.